<Anchor> A
growing number of countries are temporarily suspending AstraZeneca vaccination in Europe.
This is because there have been several reports of blood clots and blood clots in blood vessels after receiving the vaccine.
Reporter Kim Young-ah reports.
<Reporter> The
Italian government today (12th) announced that it will temporarily suspend the use of some AstraZeneca vaccines.
The discontinuation of vaccination was the quantity produced by the manufacturing unit called'ABV2856' among the AstraZeneca vaccines.
In Italy, two people who had previously received this manufacturing unit's vaccine each died of heart attack and thrombosis.
In Austria and Denmark, one person each died of thrombosis, etc., and all of them were confirmed to have received the AstraZeneca vaccine produced in a manufacturing unit called'ABV5300'.
Vaccines in this manufacturing unit have been supplied in 1 million doses in 17 European countries.
As a result, Denmark, Austria, Norway, Iceland, Romania and the Baltic States have also temporarily suspended AstraZeneca vaccination.
Of the 3 million people who received the AstraZeneca vaccine in Europe by the last 9 days of local time, all 22 cases of thrombosis were reported.
However, the European Medicines Agency says the causal relationship between vaccination and blood clots has not been confirmed.
The UK, France, Germany and Australia have also announced that they will continue to be vaccinated against AstraZeneca.
[Olivier Berand/French Minister of Health: AstraZeneca vaccination should not be stopped.
Whenever serious side effects were reported, a systematic investigation was conducted.]
Among Asian countries, Thailand said it was temporarily delaying the AstraZeneca vaccine due to safety concerns.
(Video editing: Kim Ho-jin)
▶ Different countries have different decisions, why?…
"There is no report of side effects in Korea"